Totally implantable venous access ports systems tivaps
This presentation is the property of its rightful owner.
Sponsored Links
1 / 16

Totally Implantable Venous Access Ports Systems (TIVAPS) PowerPoint PPT Presentation


  • 144 Views
  • Uploaded on
  • Presentation posted in: General

Totally Implantable Venous Access Ports Systems (TIVAPS). One cancer center prospective study. Totally Implantable Venous Access Ports Systems ( TIVAPS ). Patient Veinous integrity Normal physical activity. Medical team Access reliability Care. Prospective study 815 patients.

Download Presentation

Totally Implantable Venous Access Ports Systems (TIVAPS)

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Totally implantable venous access ports systems tivaps

TotallyImplantable Venous Access Ports Systems (TIVAPS)

One cancer center prospective study


Totally implantable venous access ports systems tivaps

TotallyImplantable Venous Access Ports Systems(TIVAPS)

  • Patient

  • Veinous integrity

  • Normal physical activity

  • Medical team

  • Access reliability

  • Care


Prospective study 815 patients

Prospective study815 patients

May 2nd 2006 – April 30th 2007


Tivaps

TIVAPS

Polysite

PEROUSE (Ivry Le Temple-France)


Totally implantable venous access ports systems tivaps

Women: 64%

56.2 years(0.8 – 85.2)

BMI = 25.03 (12.7-58.4)

Use of lowweightheparin

14%


One year tivaps

One-Year TIVAPS

24% in tumoral progression

Indication = 97% for chemotherapy

314

123

79

77

77

64

47

33


Peroperative data

PEROPERATIVE DATA

  • Local anesthesia = 91%

  • Final venous access in 96%

    • External jugular vein

    • Cephalic vein

  • Number of attempts

    • >=2 in 17%


Operating data

OPERATING DATA

Surgeon

Operating time

30 min skin to skin


First use of tivaps

FIRST USE OF TIVAPS

%

  • Median time= 8 days (0 – 135)

  • Use easiness

    • 0 = easy

    • 7 = hard


Tiaps and morbidity 2006 2007

TIAPS and Morbidity2006-2007

16.1%

LITT = 8.6-31%

Schwarz RE et al . Cancer 1999;79:1635

Kock HJ et al. World J Surg 1998;22:12

Lersch C et al. Oncology 1999;57:269

Aldrighetti L et al. J Vasc Access 2000;1:28

Chang HM et al. Eur J Surg Oncol 2006;32:90

Shetty PC et al. J Vasc Interv Radiol 1997;8:991

Hata Y et al. Cardiovasc Intervent Radiol 1998;21:230

Zahringer M et al. Rofo 2006;178:324

Cil BE et al. Diagn Interv Radiol 2006;12:93

Marcy PY et al. Cancer 2007;110:2331


Morbidit cci 2006 2007

Morbidité CCI2006-2007

Morbidity=16.1%

Death=0

N=131/815


Causes for early removal of tivaps

Causes for early removal of TIVAPS

  • N=55 (6.8%)

  • Median time before removal

    • 3.7 months (0.2-12)

  • 60%

    • Infection

    • Incision dehiscence


Facteurs pr dictifs complications

Facteurs prédictifs complications

DELAI pose-1ère utilisation

Difficulté de pose

  • Complications

    • Infection+++

    • Cutaneous troubles+++

    • Inflammation

    • Incision Dehiscence


Predictive factors of complication

Predictive factors of complication

Not to use TIVAPS before 8 days


Totally implantable venous access ports systems tivaps

Not to use TIVAPS before 8 days

Key points for improvement

Hind et al BMJ 2003;327:361. Metaanalysis

Narducci et al EJSO 2011;37,913

Decrease of early removal for complication

Infection

Cutaneous troubles

Incision dehiscence

Increase rate of success

with first attempt (> 83%)

  • ULTRA SOUND GUIDED VENIPUNCTURE

  • 90% success rate of puncture

  • complications (anatomic variations)

  • operating time (20 min)

  • patient comfort


  • Login